.jpg)
.png)
Last Updated: Thursday, 16-May-2019 19:15:00 EDT
MIAMI, Fla. – (May 16, 2019) – The NLA has released a statement paper that provides updated guidance to clinicians to help identify patient groups in whom treatment with PCSK9 monoclonal antibodies (mAbs) provides a reasonable value.
Article By:
JOYCE L. ROSS, MSN, CRNP, CLS, FPCNA, FNLA
Past President, National Lipid Association
Consultative Education Specialist, Cardiovascular Risk Intervention
University of Pennsylvania Health System - Retired
Philadelphia, PA
We have come a very long way along the road of understanding the pathophysiology of cardiovascular vascular disease. Historical theories regarding atherogenesis proposed in the 19th century are now being validated.
Article By:
KAYE-EILEEN WILLARD, MD, FNLA
Editor, LipidSpin
Medical Director, Lipid Clinic and Physician Advisor
Ascension Wisconsin All Saints
Racine, WI
Diplomate, American Board of Clinical Lipidology
“They may forget your name, but they will never forget how you made them feel.”
- Maya Angelou
Article By:
JUDITH COLLINS, MSN, APRN-BC, CVN-BC, FPCNA, CLS, FNLA
Cardiovascular Nurse Practitioner
Montrose Cardiology
Montrose, CO
Last Updated: Monday, 29-Apr-2019 13:00:00 EDT
The NLA released an official scientific statement on Lipoprotein(a) [Lp(a)] designed as a comprehensive source of guidance for medical professionals making decisions to improve the health and well-being of children and adults at risk of premature cardiovascular disease.
Last Updated: Friday, 12-Apr-2019 17:00:00 EDT
JACKSONVILLE, Fla. (April 12, 2019) — The 2019 National Lipid Association Nominating Committee released its annual report and recommendations on Monday.
Last Updated: Friday, 12-Apr-2019 12:15:00 EDT
Pursuant to the advice of the Chapter of the National Lipid Association, the following updates to the Bylaws are proposed to the NLA membership for adoption at the NLA Business Meeting on May 18, 2019. The purpose of the update is to restore the position of the at-large directors on the chapter boards of directors and eliminate the regional representative position. You may review the proposed changes by downloading the document at the link below.
I would like to thank everyone who supported the Foundation of the National Lipid Association in 2018 by volunteering to work on our patient resource initiatives or awareness campaigns, attending a fundraiser, purchasing a Lipids Are My Life shirt at an NLA conference, speaking with your colleagues and patients about the Foundation or making a donation.
Article By:
ANNE C. GOLDBERG, MD, FNLA
President, Foundation of the National Lipid Association
Associate Professor of Medicine
Washington University School of Medicine
St. Louis, MO
Diplomate, American Board of Clinical Lipidology
Q: Could you tell us about what drew you to preventive cardiology?
Article By:
WENJUN FAN, MS
PhD Candidate
University of California-Irvine
Irvine, CA
Introduction
Article By:
ALYSSA LYNOTT, RDN, LD
Nutrition/Wellness Coach, Wellness Center
Idaho State University
Kasiska Division of Health Sciences
Pocatello, ID
CAROL KIRKPATRICK, PHD, MPH, RDN, CLS, FNLA
Director, Wellness Center
Idaho State University
Kasiska Division of Health Sciences
Pocatello, ID
GEETA SIKAND, MA, RDN, CDE,CLS, FNLA
Director of Nutrition
Preventive Cardiology Program
Associate Clinical Professor of Medicine (Cardiology)
University of California Irvine
Irivine, CA